Reference : Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer...
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells
Buytaert, E. [> >]
Matroule, J. Y. [> >]
Durinck, S. [> >]
Close, Pierre mailto [Université de Liège - ULiège > Département de pharmacie > Chimie médicale >]
Kocanova, S. [> >]
Vandenheede, J. R. [> >]
de Witte, P. A. [> >]
Piette, Jacques mailto [Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Virologie - Immunologie >]
Agostinis, P. [> >]
Nature Publishing Group
Yes (verified by ORBi)
United Kingdom
[en] Photodynamic therapy (PDT) is an anticancer approach utilizing a light-absorbing molecule and visible light irradiation to generate, in the presence of O(2), cytotoxic reactive oxygen species, which cause tumor ablation. Given that the photosensitizer hypericin is under consideration for PDT treatment of bladder cancer we used oligonucleotide microarrays in the T24 bladder cancer cell line to identify differentially expressed genes with therapeutic potential. This study reveals that the expression of several genes involved in various metabolic processes, stress-induced cell death, autophagy, proliferation, inflammation and carcinogenesis is strongly affected by PDT and pinpoints the coordinated induction of a cluster of genes involved in the unfolded protein response pathway after endoplasmic reticulum stress and in antioxidant response. Analysis of PDT-treated cells after p38(MAPK) inhibition or silencing unraveled that the induction of an important subset of differentially expressed genes regulating growth and invasion, as well as adaptive mechanisms against oxidative stress, is governed by this stress-activated kinase. Moreover, p38(MAPK) inhibition blocked autonomous regrowth and migration of cancer cells escaping PDT-induced cell death. This analysis identifies new molecular effectors of the cancer cell response to PDT opening attractive avenues to improve the therapeutic efficacy of hypericin-based PDT of bladder cancer.

File(s) associated to this reference

Fulltext file(s):

Restricted access
Buytaert et al, 2008.pdfPublisher postprint478.66 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.